Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122435404 | 12243540 | 4 | F | 20160118 | 20160426 | 20160406 | 20160722 | EXP | IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-023972 | BRISTOL MYERS SQUIBB | 58.35 | YR | M | Y | 0.00000 | 20160722 | CN | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122435404 | 12243540 | 1 | PS | METFORMIN HYDROCHLORIDE. | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, UNK | 20357 | 500 | MG | TABLET | |||||||
| 122435404 | 12243540 | 2 | SS | XANAX | ALPRAZOLAM | 1 | Oral | 0.50 MG, UNK | 0 | .5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122435404 | 12243540 | 1 | Weight control |
| 122435404 | 12243540 | 2 | Weight control |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122435404 | 12243540 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122435404 | 12243540 | Drug abuse | |
| 122435404 | 12243540 | Intentional overdose | |
| 122435404 | 12243540 | Off label use | |
| 122435404 | 12243540 | Sopor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122435404 | 12243540 | 1 | 20160118 | 0 | ||
| 122435404 | 12243540 | 2 | 20160118 | 0 |